Clonal spread of Neisseria meningitidis of serogroup W135

Citation
Mk. Taha et al., Clonal spread of Neisseria meningitidis of serogroup W135, PRESSE MED, 30(31), 2001, pp. 1535-1538
Citations number
12
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
PRESSE MEDICALE
ISSN journal
07554982 → ACNP
Volume
30
Issue
31
Year of publication
2001
Part
1
Pages
1535 - 1538
Database
ISI
SICI code
0755-4982(20011027)30:31<1535:CSONMO>2.0.ZU;2-X
Abstract
Objectives Efficient surveillance of communicable diseases involves close c ollaboration between physicians, epidemiologist and bacteriologists. The ch aracterization of meningococcal infections is a medical emergency due to th eir lethality and their epidemic behavior. The recent expansion of Neisseri a meningitidis of serogroup W135 among pilgrims and their contacts underlin es the need of a multidisciplinary procedure of alert. Methods Meningococcal strains are usually received by the National Referenc e Center for Meningococci (CNRM). They are identified and then typed to det ermine their antigenic formula (serogroup:serotype: serosubtype). For clust er analysis, the CNRM as well as the WHO collaborating center, perform mole cular typing of isolated strains. Should an epidemic is suspected, the Inst itut de Veille Sanitaire and the Direction Generale de la Sante, are immedi ately informed Results Between the 22th of March and the 20th of November 2000, 27 cases o f systemic meningococcal infections due to N. meningitidis the antigenic fo rmula W135:2a:P1-2,5 were identified. Molecular typing of these strains sho wed that they were clonal and belonged to the complex ET-37. The disseminat ion of this clone among pilgrims who were vaccinated against serogroups A a nd C may suggest the selection of a new variant by an escape alteration in the capsule. However, such strains were detected in France as early as 1994 . Conclusion The global spread of N. meningitidis of serogroup W135 belonging to the ET-37 clonal complex should be kept under a close surveillance sinc e epidemics may occur particularly in Africa. New vaccination procedures (q uadrivalent vaccines and multivalent conjugate meningococcal vaccines) are therefore needed. (C) 2001, Masson, Paris.